Press Releases & Statements connected to "Drug Pricing"

September 22, 2021

New Poll Highlights Seniors’ Priorities and Concerns in Prescription Drug Pricing Legislation, Misalignment with Congress on Definition of Negotiation

Results from a new Morning Consult poll commissioned by the Alliance for Aging Research illustrate the priorities of older…
September 9, 2021

132 Patient, Disability & Provider Organizations Urge Congress to Enact Meaningful Reforms to Improve Prescription Drug Affordability for Older Adults in Medicare Part D

Today, the Alliance for Aging Research (“Alliance”) and 131 other organizations representing older Americans, patients, family caregivers, people with disabilities,…
September 1, 2021

Alliance Submits Feedback to President Biden on Prescription Drug Pricing Reform Proposals

President Biden recently released his Principles for Lowering Drug Prices, a set of key prescription drug policy priorities. The…
July 20, 2021

Alliance Submits Feedback on Chairman Wyden’s Principles for Lowering Drug Prices

Senator Ron Wyden (D-OR) recently released his Principles for Lowering Drug Prices for Americans, a framework to guide additional…
May 24, 2021

Alliance for Aging Research Outlines Drug Pricing Priorities to Congressional Leadership

Today the Alliance for Aging Research sent a letter to Congressional leadership outlining principles for patient-centered drug pricing reform. In…
May 21, 2021

Alliance for Aging Research Thanks House Democrats for Seeking Bipartisan Approach to Drug Pricing Reform

Today the Alliance for Aging Research sent a letter to Democratic members in the U.S. House of Representatives that have…
May 12, 2021

New Report Describes Better Framework for Assessing Value of Alzheimer’s Treatments

Today the Alliance for Aging Research released a report, “Assessing the Value of Therapies in Alzheimer’s Disease: Considerations…
May 4, 2021

Alliance Submits Testimony for Energy & Commerce Committee Hearing on Prescription Drug Costs

On May 4, 2021, the House Committee on Energy & Commerce held a hearing entitled “Negotiating a Better Deal: Legislation…
April 22, 2021

New Analysis Shows International Reference Drug Pricing Would Have a Catastrophic Impact on Alzheimer’s Disease Research

The number of Americans aged 65 and older with Alzheimer´s disease (AD) is expected to more than double from 6.2…
April 14, 2021

The Alliance for Aging Research Joins Over 80 Groups in Urging Congress to Reject Methodologies that Reinforce Health Inequities

Over 80 national organizations representing patients and people with disabilities signed a letter to lawmakers urging them to reject policies…
April 13, 2021

Alliance for Aging Research Congratulates the Honorable Xavier Becerra on his Confirmation as HHS Secretary

Department of Health and Human Services Secretary Xavier Becerra The Alliance for Aging Research commends the Biden Administration and the…
January 27, 2021

Alliance Submits Comments to CMS on Most Favored Nation Interim Final Rule

On Tuesday, January 26, 2021, the Alliance for Aging Research submitted a comment letter to the Centers for Medicare &…
December 16, 2020

Alliance for Aging Research Files Brief Encouraging Federal Court to Delay Implementation of Administration’s Most Favored Nation Rule

On Tuesday, December 15, 2020, the Alliance for Aging Research filed an amicus curiae brief, urging the United States…
July 24, 2020

Alliance for Aging Research Statement Opposing President Trump’s Executive Order on the International Pricing Index

Alliance for Aging Research President and CEO Susan Peschin, MHS, issued the following statement: Today the President signed an Executive…
July 20, 2020

Patient Advocacy Groups Call for Bipartisan Action to Alleviate Older Americans’ Undue Medicare Part D Cost Burden

Before the Coronavirus disease 2019 (COVID-19) pandemic, many older Americans and people with chronic diseases were foregoing their prescribed medications…